BOCA RATON, Fla., Dec. 18, 2006 (PRIME NEWSWIRE) -- OTC Briefing.com issues new trade alert for BioSante Pharmaceuticals, Inc. (AMEX:BPA). According to M. D'Alonzo at First Equity Group Inc., "Recent news flow from the company has been very positive. The company announced that it received U.S. Food and Drug Administration (FDA) approval for the marketing of Bio-E-Gel(r) (estradiol gel) in the United States. Bio-E-Gel, which will be marketed under the name Elestrin(tm), is indicated for the treatment of moderate-to-severe vasomotor symptoms (hot flashes) associated with menopause. Two doses of Elestrin(tm), 0.87 grams per day and 1.7 grams per day, were approved. Elestrin(tm) 0.87 grams per day is the lowest dose of estradiol approved by the FDA for the treatment of moderate-to-severe vasomotor symptoms.
About Elestrin(tm)
Elestrin is a fast-drying gel formulation of bio-identical estradiol, the same estrogen produced naturally in women. Elestrin was developed to be absorbed through the skin after topical application on the upper arm, and delivers estradiol to the bloodstream evenly over time in a non-irritating, painless manner. Elestrin is administered using a metered dose applicator that delivers 0.87 g of gel per actuation, thereby allowing for precise titration from dose to dose. The gel dries quickly in one to two minutes.
About OTC Briefing.com
OTC Briefing.com was developed solely for experienced, risk-tolerant investors. Subscribers to OTC Briefing.com receive daily market commentary reports for select companies trading on various markets. Sophisticated investors are also able to receive for free, select, rare research reports and investor kits on up and coming emerging companies while they are still not widely known.
OTC Briefing.com's primary focus is promoting awareness among brokers, investors, and others in the investment community who are interested in small- and micro-cap companies. OTC Briefing.com is dedicated to helping publicly traded companies gain the exposure they need to move forward with the development of their business plans. OTCB's goal is to feature equity investments in micro- or small-capitalization companies that have the potential for long-term appreciation. OTCB provides investors with a complete suite of online interactive financial data and tools that includes quotes, charts, company profiles, news, market commentary and SEC filings, just to name a few. OTC Briefing.com offers a free financial newsletter. To subscribe or get more information, visit our home page located at OTC Briefing.com. Let Stock First Equity Group help advertise for your company using our effective awareness campaigns. If you're interested in telling your story, we can help. Contact us at info@otcbriefing.com. OTCB's e-mail alert service is free to those investors who sign up on the OTCB home page. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to Special Situation companies that have the potential of showing increased activity. To subscribe to this free service, visit the OTC Briefing Alert home page at OTC Briefing.com and select the "sign up" button.
Information contained herein is the opinion of OTC Briefing.com and is intended to be used strictly for informational purposes. You should be aware that OTCB attempts to assure itself of the accuracy of the information contained in the analyses it publishes. In this regard, OTCB does, at times, rely on the accuracy of information supplied to it by the companies, which are the subject of OTCB's analyses and/or parties related to those companies. OTCB also relies on the accuracy and integrity of information that is contained in company press releases and reports filed with the SEC. The companies mentioned in this publication have not approved the content or timing of the information being published unless otherwise noted.
OTCB, because it relies on information supplied by various third parties, disclaims any responsibility for the accuracy of such information. Any investor considering making an investment in any security which has been the subject of a OTCB analysis or opinion should, before making any such investment, consult with his/her market professional and/or do his/her own independent research regarding the company which is the subject of an OTCB opinion, recommendation or analysis.
Information regarding companies, which OTCB has an opinion upon, is normally available from many sources including the subject company's filings with the SEC and various press releases issued by the company.
All material herein is information supplied by the company or other sources believed to be reliable. The information contained herein is not guaranteed by First Equity Group, Inc. to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this profile have approved the statements made in this profile. This profile contains forward-looking statements that involve risks and uncertainties. Statements in this press release about the company's future expectations other than historical facts, are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, section 21E of the Securities Act of 1934, as that term is defined in the Private Securities Litigation Reform Act of 1995. It is important to note that actual results and ultimate corporate actions could differ materially from those in such forward-looking statements. Such "forward-looking statements" are subject to risks and uncertainties set forth from time to time in the company's SEC reports that could cause results to differ materially from those expressed or implied include, but are not limited to, the results of future tests and the availability of funding for additional research and development. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. First Equity Group is not a licensed broker, broker dealer, market maker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.otcbriefing.com. First Equity Group may have purchased shares on the open market or in a private placement. First Equity Group's affiliates, officers, directors, and employees may also have bought or may buy the shares discussed in this profile and may profit in the event those shares rise in value. First Equity Group does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.